Risk and Prognosis of Secondary Bladder Cancer After Radiation Therapy for Rectal Cancer: A Large Population-Based Cohort Study

Abstract

BackgroundAlthough radiation therapy (RT) improves local control for rectal cancer (RC), the long-term risks from RT, including development of a secondary malignancy, are controversial. The risk and prognosis of secondary bladder cancer (SBC) in RC patients undergoing RT have not been adequately studied. Our goal is to investigate the impact of RT on the risk of developing SBC and assess their survival outcomes.MethodsThis large population-based study included RC patients as their initial primary cancer from nine registries of the Surveillance, Epidemiology and End Results (SEER) database between 1973 and 2015. The cumulative incidence of SBC was assessed by using Fine and Gray’s competing risk regression. The standardized incidence ratio (SIR) was used to compare the incidence of SBC in RC survivors to the US general population. The Kaplan-Meier method was used to evaluate the 10-year overall survival (OS) and 10-year cancer specific survival (CSS) for patients with SBC.ResultsOf 74,646 RC patients, 24,522 patients were treated with surgery and RT and 50,124 patients were treated with surgery alone. The incidence of SBC was 1.85% among patients who received RT and 1.24% among patients who did not. The incidence of SBC in RC patients who received RT was higher than the US general population (SIR, 1.35; 95% CI, 1.19-1.53, P<0.05), and decreased with increasing age at diagnosis, and increased with time since diagnosis. In competing risk regression analysis, undergoing RT was associated with a higher risk of SBC (hazard ratio [HR], 1.443, 95% confidence interval [CI], 1.209-1.720; P<0.001). The results of the dynamic SIR for SBC revealed that a slightly increased risk of SBC was observed after RT in the early latency, and was significantly related to the variations of age at RC diagnosis and decreased with time progress. The 10-year OS and CSS among SBC patients after RT were comparable to SBC patients after NRT.ConclusionRadiation was associated with an increased risk of developing SBC in RC patients, and special attention should be paid to the surveillance of these patients.

Incident Cardiovascular Disease Among Adults With Cancer

“…Indeed, a recent study using data from the SEER database found that patients with breast cancer not exposed to chemotherapy or radiotherapy were at higher risk for incident CV disease compared with the general population, especially without tumor resection. 30 …”

Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer

“…During RT, high doses of ionizing radiation are delivered, which is a form of high-energy electromagnetic radiation reaching deeper internal body structures and eventually causing apoptosis ( 8 , 9 ). However, RT increases the risk of developing radiation-induced complications in normal tissues and may promote progressive changes in the extracellular matrix and the development of a vascular reaction, which could increase the risk of secondary tumors in the irradiated field ( 4 , 10 , 11 ). The bladder is usually within the field of irradiation in the pelvis and is exposed to more radiation than organs in the non-pelvic area ( 12 ).…”

Neoadjuvant Chemotherapy plus Bevacizumab Combined with Total Mesorectal Excision in Treating Locally Advanced Rectal Cancer Patients with BRAF Mutation: Clinical Benefit and Safety

“…Although it can reduce the local relapse rate of patients, evident survival benefits were not achieved in terms of longterm efficacy [3,4]. In addition, due to the high damage of radiotherapy to LARC patients, anal function, urination function, and sexual function worsen with time, which dramatically reduces the patient's life quality and increases the risk for secondary tumors such as bladder cancer [5][6][7]. With the continuous development of TME-related techniques in clinical practice, both the R0 resection rate and anus preservation rate are becoming more and more ideal.…”